Should You Accumulate Kinnate Biopharma Inc (KNTE) Stock Wednesday?

Wednesday, September 27, 2023 10:28 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Kinnate Biopharma Inc (KNTE) Stock Wednesday?

Kinnate Biopharma Inc (KNTE) stock is lower by -88.18% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives KNTE stock a score of 34 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 2. KNTE's rank also includes a short-term technical score of 7.

KNTE has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on KNTE!

See Full KNTE Report

What's Happening with KNTE Stock Today

Kinnate Biopharma Inc (KNTE) stock has gained 4.35% while the S&P 500 is higher by 0.24% as of 10:25 AM on Wednesday, Sep 27. KNTE is higher by $0.06 from the previous closing price of $1.38 on volume of 3,666 shares. Over the past year the S&P 500 has gained 17.46% while KNTE is lower by -88.18%. KNTE lost -$2.82 per share in the over the last 12 months. Click Here to get the full Stock Report for Kinnate Biopharma Inc stock.